Dodds P A, Bellamy C M, Muirhead R A, Perry R A
Cardiothoracic Centre, Liverpool.
Br Heart J. 1995 Jan;73(1):25-31. doi: 10.1136/hrt.73.1.25.
The exact mechanism that explains the phenomenon of cold intolerance in patients with angina remains controversial. Although the response to the effects of a cold environment has been examined in these patients, their response to cold air inhalation has produced conflicting results. In addition, the possible role of vasoactive peptides in the pathophysiology has not been explored.
The aims of this study were to examine the response of patients with stable angina to the effects of cold air inhalation during exercise testing, and to investigate the possible role played by the vasoconstrictor peptides endothelin-1 (ET-1) and angiotensin-II (AT-II) in the pathophysiology.
In a randomised order, 12 men with stable angina, whose medication had been stopped, underwent two separate symptom limited treadmill exercise tests. At one visit the patients exercised while breathing room air and at the other visit they exercised while breathing cold air from a specially adapted freezer. Serial peripheral venous blood samples were taken for ET-1 and AT-II estimations during each visit.
Cold air inhalation resulted in a significant reduction in the mean time to angina (232.7 (20.4) s v 274.1 (26.9) s, P = 0.04) and the mean total exercise time (299.5 (27.0) s v 350.3 (23.9) s, P = 0.008), but no significant change in the time to 1 mm ST depression (223.3 (29.0) s v 241.3 (29.2) s, P = 0.25). There was no significant difference between the rate-pressure products at the onset of angina (P = 0.13) and the time to 1 mm ST depression (P = 0.85), but at peak exercise the rate-pressure product was significantly lower in patients breathing cold air as opposed to room air (P = 0.049). There was an equivalent significant decrease in ET-1 concentrations at peak exercise compared with that at rest at both visits (room air 5.0 (0.7) pmol/l v 4.3 (0.7) pmol/l, P = 0.03; cold air 4.4 (0.6) pmol/l v 3.8 (0.5) pmol/l, P = 0.02). There was a significant increase in AT-II concentrations 10 min after peak exercise in patients breathing room air (39.2 (6.1) pmol/l v 32.1 (4.8) pmol/l, P = 0.01) which was not repeated during cold air inhalation (36.6 (3.4) pmol/l v 28.3 (3.4) pmol/l, P = 0.07).
Cold air inhalation in patients with stable angina results in an earlier onset of angina and a reduction in exercise capacity. Both peripheral and central reflex mechanisms appear to contribute to the phenomenon of cold intolerance. Peripheral ET-1 and AT-II do not appear to play a significant role in the pathophysiology.
解释心绞痛患者不耐寒现象的确切机制仍存在争议。尽管已经研究了这些患者对寒冷环境影响的反应,但他们对冷空气吸入的反应却产生了相互矛盾的结果。此外,血管活性肽在病理生理学中的可能作用尚未得到探索。
本研究的目的是在运动试验期间检查稳定型心绞痛患者对冷空气吸入影响的反应,并研究血管收缩肽内皮素-1(ET-1)和血管紧张素-II(AT-II)在病理生理学中可能发挥的作用。
12名稳定型心绞痛男性患者在停药后,按照随机顺序进行了两次单独的症状限制性跑步机运动试验。在一次就诊时患者呼吸室内空气进行运动,在另一次就诊时他们呼吸来自特制冷冻机的冷空气进行运动。每次就诊期间采集系列外周静脉血样本用于ET-1和AT-II测定。
吸入冷空气导致心绞痛平均发作时间显著缩短(232.7(20.4)秒对274.1(26.9)秒,P = 0.04)和平均总运动时间显著缩短(299.5(27.0)秒对350.3(23.9)秒,P = 0.008),但ST段压低1毫米的时间无显著变化(223.3(29.0)秒对241.3(29.2)秒,P = 0.25)。心绞痛发作时的心率-血压乘积(P = 0.13)和ST段压低1毫米的时间(P = 0.85)之间无显著差异,但在运动高峰时,与呼吸室内空气的患者相比,呼吸冷空气的患者心率-血压乘积显著更低(P = 0.049)。与两次就诊时的静息状态相比,运动高峰时ET-1浓度均显著降低(室内空气:5.0(0.7)pmol/L对4.3(0.7)pmol/L,P = 0.03;冷空气:4.4(0.6)pmol/L对3.8(0.5)pmol/L,P = 0.02)。呼吸室内空气的患者在运动高峰后10分钟时AT-II浓度显著升高(39.2(6.1)pmol/L对32.1(4.8)pmol/L,P = 0.01),而在吸入冷空气期间未出现这种情况(36.6(3.4)pmol/L对28.3(3.4)pmol/L,P = 0.07)。
稳定型心绞痛患者吸入冷空气会导致心绞痛更早发作并降低运动能力。外周和中枢反射机制似乎都促成了不耐寒现象。外周ET-1和AT-II在病理生理学中似乎未发挥重要作用。